BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1268 related articles for article (PubMed ID: 16506291)

  • 1. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
    Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
    Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
    J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental and functional analyses of CD8(+) NK1.1(+) T cells in class-I-restricted TCR transgenic mice.
    Ohwatari R; Iwabuchi K; Iwabuchi C; Morohashi T; Sawa H; Hioki K; Kobayashi K; Fukuda S; Inuyama Y; Onoé K
    Cell Immunol; 2001 Oct; 213(1):24-33. PubMed ID: 11747353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
    Mannoor MK; Weerasinghe A; Halder RC; Reza S; Morshed M; Ariyasinghe A; Watanabe H; Sekikawa H; Abo T
    Cell Immunol; 2001 Aug; 211(2):96-104. PubMed ID: 11591113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of Ly49 expression on CD4+ and CD4-CD8- (double negative) NK1.1+ T cells.
    Sköld M; Cardell S
    Eur J Immunol; 2000 Sep; 30(9):2488-96. PubMed ID: 11009081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D.
    Voyle RB; Beermann F; Lees RK; Schümann J; Zimmer J; Held W; MacDonald HR
    J Exp Med; 2003 Apr; 197(7):919-25. PubMed ID: 12682111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4.
    Ueda N; Kuki H; Kamimura D; Sawa S; Seino K; Tashiro T; Fushuku K; Taniguchi M; Hirano T; Murakami M
    Int Immunol; 2006 Sep; 18(9):1397-404. PubMed ID: 16914507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of CD4-CD8- alpha beta TCR+NK1.1+ T lymphocytes: thymic selection by self antigen.
    Schulz RJ; Parkes A; Mizoguchi E; Bhan AK; Koyasu S
    J Immunol; 1996 Nov; 157(10):4379-89. PubMed ID: 8906813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type.
    Stenström M; Sköld M; Ericsson A; Beaudoin L; Sidobre S; Kronenberg M; Lehuen A; Cardell S
    Eur J Immunol; 2004 Jan; 34(1):56-65. PubMed ID: 14971030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
    Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
    Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
    Sköld M; Faizunnessa NN; Wang CR; Cardell S
    J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of NK1.1(+) invariant Valpha19 TCR(+) cells in the liver with potential to promptly respond to TCR stimulation.
    Shimamura M; Huang YY; Migishima R; Yokoyama M; Saitoh T; Yamamura T
    Immunol Lett; 2008 Nov; 121(1):38-44. PubMed ID: 18789972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology. T before NK.
    MacDonald HR
    Science; 2002 Apr; 296(5567):481-2. PubMed ID: 11964466
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
    Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S
    Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invariant NKT and NKT-like lymphocytes: two different T cell subsets that are differentially affected by ageing.
    Peralbo E; Alonso C; Solana R
    Exp Gerontol; 2007 Aug; 42(8):703-8. PubMed ID: 17604928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NKT cells: T lymphocytes with innate effector functions.
    Van Kaer L
    Curr Opin Immunol; 2007 Jun; 19(3):354-64. PubMed ID: 17428648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD1d-independent developmental acquisition of prompt IL-4 gene inducibility in thymus CD161(NK1)-CD44lowCD4+CD8- T cells is associated with complementarity determining region 3-diverse and biased Vbeta2/Vbeta7/Vbeta8/Valpha3.2 T cell receptor usage.
    Chen YT; Kung JT
    J Immunol; 2005 Nov; 175(10):6537-50. PubMed ID: 16272308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective requirement for c-Myc at an early stage of V(alpha)14i NKT cell development.
    Mycko MP; Ferrero I; Wilson A; Jiang W; Bianchi T; Trumpp A; MacDonald HR
    J Immunol; 2009 Apr; 182(8):4641-8. PubMed ID: 19342639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.